Literature DB >> 2304207

Ineffectiveness and comparative pathogenicity of attenuated rabies virus vaccines for the striped skunk (Mephitis mephitis).

C E Rupprecht1, K M Charlton, M Artois, G A Casey, W A Webster, J B Campbell, K F Lawson, L G Schneider.   

Abstract

Three attenuated rabies virus vaccines (SAD-B19, ERA/BHK-21, AZA 2) were compared for efficacy and safety in the striped skunk (Mephitis mephitis) by the oral and intranasal routes. The SAD-B19 and ERA/BHK-21 vaccines were given orally; all three vaccines were given intranasally. Oral administration of SAD-B19 and ERA/BHK-21 vaccines induced neither seroconversion nor significant protection against rabies challenge. One skunk which consumed a SAD-B19 vaccine-laden bait succumbed to vaccine-induced rabies. Intranasal instillation of the three vaccines resulted in the deaths of two of six (AZA 2), three of six (ERA/BHK-21) and six of six (SAD-B19) skunks.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2304207     DOI: 10.7589/0090-3558-26.1.99

Source DB:  PubMed          Journal:  J Wildl Dis        ISSN: 0090-3558            Impact factor:   1.535


  14 in total

1.  An epidemic of sylvatic rabies in Finland--descriptive epidemiology and results of oral vaccination.

Authors:  M Nyberg; K Kulonen; E Neuvonen; C Ek-Kommonen; M Nuorgam; B Westerling
Journal:  Acta Vet Scand       Date:  1992       Impact factor: 1.695

2.  Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife.

Authors:  M Artois; K M Charlton; N D Tolson; G A Casey; M K Knowles; J B Campbell
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

3.  Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.

Authors:  K M Charlton; M Artois; L Prevec; J B Campbell; G A Casey; A I Wandeler; J Armstrong
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

Review 4.  The ascension of wildlife rabies: a cause for public health concern or intervention?

Authors:  C E Rupprecht; J S Smith; M Fekadu; J E Childs
Journal:  Emerg Infect Dis       Date:  1995 Oct-Dec       Impact factor: 6.883

5.  Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.

Authors:  R Pulmanausahakul; M Faber; K Morimoto; S Spitsin; E Weihe; D C Hooper; M J Schnell; B Dietzschold
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines.

Authors:  Jesse D Blanton; Joshua Self; Michael Niezgoda; Marie-Luise Faber; Bernhard Dietzschold; Charles Rupprecht
Journal:  Vaccine       Date:  2007-08-22       Impact factor: 3.641

7.  Persistence of genetic variants of the arctic fox strain of Rabies virus in southern Ontario.

Authors:  Susan A Nadin-Davis; Frances Muldoon; Alexander I Wandeler
Journal:  Can J Vet Res       Date:  2006-01       Impact factor: 1.310

8.  A novel rabies vaccine based on a recombinant parainfluenza virus 5 expressing rabies virus glycoprotein.

Authors:  Zhenhai Chen; Ming Zhou; Xiudan Gao; Guoqing Zhang; Guiping Ren; Clement W Gnanadurai; Zhen F Fu; Biao He
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

9.  A new rabies vaccine based on a recombinant ORF virus (parapoxvirus) expressing the rabies virus glycoprotein.

Authors:  Ralf Amann; Jörg Rohde; Ulrich Wulle; Douglas Conlee; Rudiger Raue; Olivier Martinon; Hanns-Joachim Rziha
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

10.  Immunogenicity studies in carnivores using a rabies virus construct with a site-directed deletion in the phosphoprotein.

Authors:  Ad Vos; Karl-Klaus Conzelmann; Stefan Finke; Thomas Müller; Jens Teifke; Anthony R Fooks; Andreas Neubert
Journal:  Adv Prev Med       Date:  2011-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.